Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiRNA profiling in Breast Cancer

ABSTRACT: To exploit molecular subtyping for risk stratification in breast cancer patients

ORGANISM(S): Homo sapiens

SUBMITTER: Orazio Palumbo

PROVIDER: E-MTAB-13550 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Federated deep learning enables cancer subtyping by proteomics

Project description:Artificial intelligence (AI) applications in biomedical settings face challenges such as data privacy and regulatory compliance. Federated Deep Learning (FDL) effectively addresses these issues. We developed ProCanFDL, where local models were trained on simulated sites using proteomic data drawn from a pan-cancer cohort (n = 1,260) and 29 other cohorts (n = 6,265), representing 4,956 patients and 19,930 mass spectrometry (MS) runs, all held behind private firewalls. Local parameter updates were aggregated to build the global model, achieving a 43% performance gain over local models on the hold-out test set (n = 625) in 14 cancer subtyping tasks. Additionally, ProCanFDL preserved data privacy while matching centralized model performance. External validation assessed generalization by retraining the global model with data from two external cohorts (n = 55) and eight (n = 832) using a different MS technology. ProCanFDL presents a solution for internationally collaborative machine learning initiatives using proteomic data while maintaining data privacy.

2025-05-29 | PXD056810 | Pride

miRNA profile in hereditary and sporadic breast cancer

Project description:we analyze expression of miRNAs in a cohort of male and female patients with familial breast cancer (BRCA1/2-related and BRCAX) and in a subset of sporadic breast cancer

2015-07-01 | E-MTAB-2705 | biostudies-arrayexpress

Molecular subtyping of breast cancer by transcription profiling

Project description:Breast cancer was one of the first cancer types where molecular subtyping led to explanation of interpersonal heterogeneity and resulted in improvement of treatment regimen. Several multigene classifiers have been developed and in particular those defining molecular signatures of early breast cancers possess significant prognostic information. Hence since 2014, molecular subtyping of primary breast cancers was implemented as a part of routine diagnostics with direct impact of therapy assignment. In this study, we evaluate direct and potential benefits of molecular subtyping in low-risk breast cancers as well as present the advantages of a robust molecular signature in regard to patient work-up among high-risk breast cancers.

2017-12-01 | E-MTAB-5724 | biostudies-arrayexpress

Microarray gene expression analyses of DMBA/MPA induced mammary tumors

Project description:Exploration of the transcriptome of DMBA/MPA induced mammary tumors including murine subtyping

2019-02-28 | E-MTAB-7507 | biostudies-arrayexpress

Breast Cancer RNA-seq

Project description:RNA-seq was performed on breast cancer cell lines and primary tumors RNA-seq was performed on 28 breast cancer cell lines, 42 Triple Negative Breast Cancer (TNBC) primary tumors, and 42 Estrogen Receptor Positive (ER+) and HER2 Negative Breast Cancer primary tumors, 30 uninovlved breast tissue samples that were adjacent to ER+ primary tumors, 5 breast tissue samples from reduction mammoplasty procedures performed on patients with no known cancer, and 21 uninvolved breast tissue samples that were adjacent to TNBC primary tumors.

2014-06-11 | E-GEOD-58135 | biostudies-arrayexpress

Transcription profiling of human prostate samples from normal donors and prostate cancer patients

Project description:This SuperSeries is composed of the following subset Series:; GSE6604: Expression data from Normal Prostate Tissue free of any pathological alteration; GSE6605: Expression data from Metastatic Prostate Tumor; GSE6606: Expression data from Primary Prostate Tumor; GSE6608: Expression data from Normal Prostate Tissue Adjacent to Tumor Experiment Overall Design: Refer to individual Series

2008-04-06 | E-GEOD-6919 | biostudies-arrayexpress

microRNA profiling by array of paired samples tumor tissue/normal adjacent tissue from colon cancer patients

Project description:Ten arrays were performed on the RNA extracts from 10 patients' samples, each of them contained the paired samples tumor tissue/ normal adjacent tissue.

2018-01-17 | E-MTAB-5443 | biostudies-arrayexpress

Prognostic significance of overexpression of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-11-21 | E-GEOD-64258 | biostudies-arrayexpress

Highly multiplexed quantification by targeted mass spectrometry to triage protein candidate biomarkers in plasma

Project description:Despite improvements in capabilities of proteomics technologies, the introduction of new plasma-based protein biomarkers for clinical use remains low. One reason is the cumbersome requirement to test thousands of protein candidates in follow-up quantitative verification studies. We sought to evaluate internal standard triggered parallel reaction monitoring (IS-PRM) in the context of biomarker verification by developing a method to quantify 5,176 peptides (1,314 proteins) as candidate biomarkers for early detection of breast cancer. Method performance was characterized in a response curve showing large linear range (4 orders of magnitude) and good repeatability (median CV 7.7%). The method was applied to pools of cancer and control human plasma, detecting 893 proteins and qualifying 164 candidates to advance for further evaluation. The method shows good quantitative performance, greatly expanding the capabilities for quantification of large numbers of proteins, and is well suited for large scale relative quantification of protein sets.

2022-06-29 | PXD028306 | Pride

Human gastric mucosa Cells: hTERT-negative para cancerous tissue (Control) vs. hTERT-positive gastric cancer tissue

Project description:The miRNA expression profiles in one pair of hTERT-positive gastric cancer tissue and an hTERT-negative para-cancerous tissue. The para-cancerous tissue is at least 5cm away from the cancer tisse. The expression of hTERT of identified by immunohistochemistry before RNA extraction for miRNA assay. One pair of gastric cancer tissue and para-cancerous tissue(Control). Four replicates per array.

2013-05-21 | E-GEOD-47107 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data